ARCHIVES

Docetaxel As Adjuvant Therapy Shows Benefit Over Standard

This article is from The Cancer Letter archive.

Vol. 25 No. 6 | June 28, 2002

Download PDF Visit The Full Archive

Related Articles

Evidence Too Weak to Link Agent Orange, Cancer, IOM Says

March 22, 2002

Brawley: CMS Got it Right in Lung Cancer Screening Decision

November 14, 2014

NIH Defends NCI Sponsored Travel

December 3, 2010

Cancer Letter Skips Next Two Weeks

September 2, 1988

Psychiatric Disorders Often Overlooked By Oncologists

September 28, 2007

NCI High School Summer Program Called Successful

October 19, 1990